Guarnieri, T., Aryl hydrocarbon receptor connects inflammation to breast cancer, «INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES», 2020, 21, Article number: 5264, pp. 1 - 17 [articolo]Open Access
Guarnieri T.; Abruzzo P.M.; Bolotta A., More than a cell biosensor: Aryl hydrocarbon receptor at the intersection of physiology and inflammation, «AMERICAN JOURNAL OF PHYSIOLOGY. CELL PHYSIOLOGY», 2020, 318, pp. C1078 - C1082 [articolo]Open Access
Abruzzo PM., Matté A., Bolotta A., Federti E., Ghezzo A., Guarnieri T., Marini M., Posar A., Siciliano A., De Franceschi L., Visconti P., Plasma peroxiredoxin changes and inflammatory cytokines support the involvement of neuro-inflammation and oxidative stress in Autism Spectrum Disorder., «JOURNAL OF TRANSLATIONAL MEDICINE», 2019, 17, pp. 1 - 12 [articolo]Open Access
Guarnieri, T, Non Steroidal Anti Inflammatory Drugs as Gatekeepers Of Colon Carcinoma Highlight New Scenarios Beyond Cyclooxygenases Inhibition, «CURRENT CANCER DRUG TARGETS», 2016, 16, pp. 186 - 197 [articolo]
Goodson, W.H.; Lowe, L.; Carpenter, D.O.; Gilbertson, M.; Ali, A.M.; de Cerain Salsamendi, A.L.; Lasfar, A.; Carnero, A.; Azqueta, A.; Amedei, A.; Charles, A.K.; Collins, A.R.; Ward, A.; Salzberg, A.C.; Colacci, A.; Olsen, A.-K.; Berg, A.; Barclay, B.J.; Zhou, B.P.; Blanco-Aparicio, C.; Baglole, C.J.; Dong, C.; Mondello, C.; Hsu, C.-W.; Naus, C.C.; Yedjou, C.; Curran, C.S.; Laird, D.W.; Koch, D.C.; Carlin, D.J.; Felsher, D.W.; Roy, D.; Brown, D.G.; Ratovitski, E.; Ryan, E.P.; Corsini, E.; Rojas, E.; Moon, E.-Y.; Laconi, E.; Marongiu, F.; Al-Mulla, F.; Chiaradonna, F.; Darroudi, F.; Martin, F.L.; Van Schooten, F.J.; Goldberg, G.S.; Wagemaker, G.; Nangami, G.; Calaf, G.M.; Williams, G.; Wolf, G.T.; Koppen, G.; Brunborg, G.; Kim Lyerly, H.; Krishnan, H.; Hamid, H.A.; Yasaei, H.; Sone, H.; Kondoh, H.; Salem, H.K.; Hsu, H.-Y.; Park, H.H.; Koturbash, I.; Miousse, I.R.; Ivana Scovassi, A.; Klaunig, J.E.; Vondracek, J.; Raju, J.; Roman, J.; Wise, J.P.; Whitfield, J.R.; Woodrick, J.; Christoph, Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: The challenge ahead, «CARCINOGENESIS», 2015, 36, pp. S254 - S296 [articolo]Open Access
Thompson, Pa; Khatami, M; Baglole, Cj; Sun, J; Harris, Sa; Moon, Ey; Al-Mulla, F; Al-Temaimi, R; Brown, Dg; Colacci, A; Mondello, C; Raju, J; Ryan, Ep; Woodrick, J; Scovassi, Ai; Singh, N; Vaccari, M; Roy, R; Forte, S; Memeo, L; Salem, Hk; Amedei, A; Hamid, Ra; Lowe, L; Guarnieri, T; Bisson, Wh., Environmental immune disruptors, inflammation and cancer risk, «CARCINOGENESIS», 2015, 36, Article number: 22, pp. 232 - 253 [articolo]Open Access
Brandi G;Tavolari S;Guarnieri T;Di Marco M;Paterini P;Macchini M;Di Girolamo S;Papi A;De Rosa F;Biasco G, Antiprotease strategy in pancreatic cancer treatment: emergence from a preclinical study., «PANCREAS», 2014, 43, pp. 53 - 63 [articolo]
A. Papi; G. Storci; T. Guarnieri; S. De Carolis; S. Bertoni;
N. Avenia; A. Sanguinetti; A. Sidoni; D. Santini; C. Ceccarelli;
M. Taffurelli; M. Orlandi; M. Bonafe, Peroxisome Proliferator Activated Receptor-α/Hypoxia Inducible Factor-1α Interplay Sustains Carbonic Anhydrase IX and Apoliprotein E Expression in Breast Cancer Stem Cells, «PLOS ONE», 2013, 8, Article number: e54968, pp. 1 - 14 [articolo]Open Access
M Macchini; G Brandi; S Tavolari; T Guarnieri; M Di Marco; P Paterini; F De Rosa; S Di Girolamo; S Vecchiarelli; A Papi; G Biasco, Antiprotease strategy in combination with gemcitabine as a putative novel therapeutic approach for pancreatic cancer treatment, in: Pancreatology, Amsterdam, Academic Press (Elsevier), «PANCREATOLOGY», 2012, 12, pp. 506 - 506 (atti di: 44th Meeting of the European Pancreatic Club 2012, Praga, 20-23/06/2012) [atti di convegno-abstract]
Alessio Papi; Tiziana Guarnieri; Gianluca Storci; Donatella Santini; Claudio Ceccarelli; Mario Taffurelli; Sabrina De Carolis; Nicola Avenia; Alessandro Sanguinetti; Angelo Sidoni; Marina Orlandi; Massimiliano Bonafé, Nuclear receptors agonists exert opposing effects on the inflammation-dependent survival of breast cancer stem cells., «CELL DEATH AND DIFFERENTIATION», 2012, 19, pp. 1208 - 1219 [articolo]
Tavolari S; Munarini A; Storci G; Laufer S; Chieco P; Guarnieri T., The decrease of cell membrane fluidity by the non-steroidal anti-inflammatory drug Licofelone inhibits epidermal growth factor receptor signalling and triggers apoptosis in HCA-7 colon cancer cells., «CANCER LETTERS», 2012, 321, pp. 187 - 194 [articolo]
T. Guarnieri, 5-Lipoxygenase, in: AA.VV. - ENCYCLOPEDIA OF CANCER, ENCYCLOPEDIA OF CANCER: SpringerReference (www.springerreference.com), BERLIN, HEIDELBERG, Springer-Verlag, 2012, pp. 1 - 4 [voce di enciclopedia/dizionario]
Papi A; G Storci; T Guarnieri; D Santini; M Taffurelli; C Ceccarelli; M Orlandi; M Bonafé, PPAR-alpha nuclear receptor/ApoE axis: a new target of Breast Cancer Stem Cells, in: Convegno AICC, Atti convegno, ROMA, s.n, 2011, pp. 102 - 102 (atti di: Convegno AICC, Atti convegno, Roma, 10-13/11/2011) [atti di convegno-abstract]
Papi A; Orlandi M; Guarnieri T; Taffurelli M; Ceccarelli C; Santini D; Storci G; Bonafè M, Retinoid Receptor Ligands are Potent Anti-inflammatory Agents in Breast Cancer Stem Cells Model, in: XXII Convegno Annuale ABCD:atti del convegno, RAVENNA, s.n, 2011, pp. 100 - 100 (atti di: XXII Convegno Annuale ABCD, Ravenna, 7-9 Settembre 2011) [atti di convegno-abstract]
Macchini M; Brandi G; Tavolari S; Guarnieri T; de Rosa F; Paterini P; Di Girolamo S; Agostini V; Di Marco M; Vecchiarelli S; Di Cicilia R; Nobili E; Biasco G., The Protease Inhibitor Gabexate Mesylate Reduces Invasiveness and Angiogenesis in Pancreatic Cancer Cell Lines, Enhancing Gemcitabine Action, in: JOP. JOURNAL OF THE PANCREAS, «JOP. JOURNAL OF THE PANCREAS», 2010, 11 (5 suppl), pp. 512 - 512 (atti di: AISP - 34th National Congress., Peschiera del Garda, VR (Italy)., October 7-9, 2010) [atti di convegno-abstract]
